Journal
JOURNAL OF NEUROLOGY
Volume 253, Issue 4, Pages 483-487Publisher
DR DIETRICH STEINKOPFF VERLAG
DOI: 10.1007/s00415-005-0037-3
Keywords
multiple sclerosis; reactive oxygen species; antioxidant capacity; oxidative stress
Categories
Ask authors/readers for more resources
Background The role of oxidative stress in patients with multiple sclerosis (MS) is poorly understood. Objective To investigate oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of MS. Methods Diene conjugate (DC) levels (a measure of lipid peroxidation), total antioxidative activity (AOA) and total anti-radical activity (ARA) were measured in serum and peripheral blood leukocytes from 30 patients with benign relapsing remitting MS (BMS), 27 with secondary progressive MS (SPMS), 29 with primary progressive MS (PPMS), and 30 healthy controls. All MS patients were in a clinically stable phase. Results Serum DC levels were elevated in patients with BMS (p < 0.05), SPMS (p < 0.01) and PPMS (p < 0.001). Serum total AOA and ARA were not different between MS patients and controls. Compared to controls, leukocyte DC levels were not different in each MS subgroup, but total ARA was elevated. There was a strong correlation, both in controls and MS patients, between leukocyte D C levels and leukocyte total ARA (p < 0.0001) and leukocyte total AOA (p < 0.0001). Conclusion Oxidative stress occurs in progressive as well as benign MS. The finding that cells withstand oxidative stress, due to upregulated cellular antioxidant defence mechanisms, suggests that reactive oxygen species (ROS) formation in MS is not necessarily deleterious.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available